Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells
| dc.contributor.author | Humphrey, Emma L. | |
| dc.contributor.author | Williams, John H. H. | |
| dc.contributor.author | Davie, Michael W. J. | |
| dc.contributor.author | Marshall, Michael J. | |
| dc.date.accessioned | 2012-06-01T09:08:40Z | |
| dc.date.available | 2012-06-01T09:08:40Z | |
| dc.date.issued | 2006-05 | |
| dc.identifier.citation | Humphrey, E. L., Williams, J. H. H., Davie, M. W. J., & Marshall, M. J. (2006). Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone, 38(5), 652-661. https://doi.org/10.1016/j.bone.2005.10.004 | |
| dc.identifier.issn | 8756-3282 | en |
| dc.identifier.doi | 10.1016/j.bone.2005.10.004 | |
| dc.identifier.uri | http://hdl.handle.net/10034/227131 | |
| dc.description | This article is not available through ChesterRep. | |
| dc.description.abstract | This article demonstrates that dexamethasone, prednisolone, deflazacort and the dissociated glucocorticoids, RU24858, RU40066, RU24782, AL438-F1 and ZK216348 significantly inhibit osteoprotegerin (OPG) production in two human osteoblastic cell lines (MG63 and hFOB). | |
| dc.description.sponsorship | This article was submitted to the RAE2008 for the University of Chester - Allied Health Professions and Studies. | |
| dc.language.iso | en | en |
| dc.publisher | Elsevier | |
| dc.relation.url | http://www.journals.elsevier.com/bone/ | en_GB |
| dc.rights | Archived with thanks to Bone | en_GB |
| dc.subject | dissociated glucocorticoids | en_GB |
| dc.subject | osteoprotegerin (OPG) | en_GB |
| dc.subject | RANKL | en_GB |
| dc.subject | deflazacort | en_GB |
| dc.subject | osteoblast | en_GB |
| dc.title | Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells | en |
| dc.type | Article | en |
| dc.contributor.department | Robert Jones and Agnes Hunt Orthopaedic Hospital; University College Chester | |
| dc.identifier.journal | Bone | en_GB |
| dc.date.accepted | 2005-10-07 | |
| html.description.abstract | This article demonstrates that dexamethasone, prednisolone, deflazacort and the dissociated glucocorticoids, RU24858, RU40066, RU24782, AL438-F1 and ZK216348 significantly inhibit osteoprotegerin (OPG) production in two human osteoblastic cell lines (MG63 and hFOB). |
Files in this item
Name:
Publisher version